Abstract
Full text available
Current Drug Safety
Title: Opinion: [Withdrawal of Rimonabant – Walking the Tightrope of 21st Century Pharmaceutical Regulation?]
Volume: 4 Issue: 1
Author(s): David Taylor
Affiliation:
Abstract: Full text available
Export Options
About this article
Cite this article as:
Taylor David, Opinion: [Withdrawal of Rimonabant – Walking the Tightrope of 21st Century Pharmaceutical Regulation?], Current Drug Safety 2009; 4 (1) . https://dx.doi.org/10.2174/157488609787354396
DOI https://dx.doi.org/10.2174/157488609787354396 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
CoMFA and CoMSIA Analyses of Highly Selective Pipecolic Acid Based TNF-α Converting Enzyme (TACE) Inhibitors Using Docked Conformations for Molecular Alignment
Letters in Drug Design & Discovery The Role of Platelet/Lymphocyte Serotonin Transporter in Depression and Beyond
Current Drug Targets Synaptic Plasticity as a Therapeutic Target in the Treatment of Autism-related Single-gene Disorders
Current Pharmaceutical Design Joint Effect of ABCA7 rs4147929 and Body Mass Index on Progression from Mild Cognitive Impairment to Alzheimer’s Disease: The Shanghai Aging Study
Current Alzheimer Research Adherence to Antiretroviral Therapies: State of the Science
Current HIV Research The Synthesis of Coenzyme Q10
Current Organic Chemistry Antidepressant-Like Components of Hypericum perforatum Extracts: An Overview of Their Pharmacokinetics and Metabolism
Current Drug Metabolism Meet Our Editorial Board Member
Current Alzheimer Research CADD Modeling of Multi-Target Drugs Against Alzheimer's Disease
Current Drug Targets The Arrestin Fold: Variations on a Theme
Current Genomics Evolving Concepts Concerning Cardiac β-Adrenoceptor Function in Heart Failure
Current Pharmaceutical Design Home Oxygen Therapy for the 21st Century
Current Respiratory Medicine Reviews Using Mass Spectrometry-Based Peptidomics to understand the Brain and Disorders such as Parkinson’s Disease and Schizophrenia
Current Topics in Medicinal Chemistry Preface [Hot Topic: Perspective on VLA-4 Antagonists (Guest Editor: Jefferson W. Tilley)]
Current Topics in Medicinal Chemistry The Role of Genetics in Inflammatory Bowel Disease
Current Drug Targets Antioxidant and Enzyme Inhibitory Properties of Mangifera indica leaf Extract
The Natural Products Journal Visible Light-Induced Photocatalytic Elimination of Organic Pollutants by TiO<sub>2</sub>: A Review
Current Organic Chemistry Editorial [Hot Topic New Clinical Indications of Antipsychotic Medications Guest Editors: Filippo Bogetto and Silvio Bellino]
Current Psychopharmacology Mechanisms of MDMA (Ecstasy)-Induced Oxidative Stress, Mitochondrial Dysfunction, and Organ Damage
Current Pharmaceutical Biotechnology Systems Genomics Support for Immune and Inflammation Hypothesis of Depression
Current Neuropharmacology